share_log

Tonix Pharmaceuticals Q4 EPS $(0.86) Beats $(1.55) Estimate, Sales $3.80M Miss $5.75M Estimate

Moomoo 24/7 ·  Apr 1 16:28

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.55) by 44.52 percent. This is a 75.43 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $3.80 million which missed the analyst consensus estimate of $5.75 million by 33.91 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment